Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.44B
Enterprise Value4.32B
P/E Ratio184.49
PEG Ratio-2.32
Price/Sales Ratio1.81
Price/Book Ratio1.62
Enterprise/Revenue1.83
Enterprise/EBITDA16.22

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.01
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0
Return On Equity0.01

Income Statement

Revenue2.91B
Revenue/Share2.5
Gross Profit1.19B
EBITDA438.29M
Net Income70.56M
Diluted EPS0.07

Balance Sheet

Total Cash702.57M
Total Cash/Share0.64
Total Debt757.35M
Total Debt/Equity0.25
Current Ratio2.08
Book Value Per Share3.58

Price History

52-Week Change9.71
52-Week High8.44
52-Week Low3.68
Moving Average 50 Days5.83
Moving Average 200 Days4.7

Statistics

Average Volume119.54M
Shares Outstanding1.09B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield2.17
Payout Ratio4.6
Last Split Factor3:2
Last Split DateMarch 13, 2013
AD